MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBC
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1
Tucatinib Together With Pembrolizumab and Trastuzumab
- Status
- TERMINATED
- Phase
- PHASE2
Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX)
- Status
- RECRUITING
- Phase
- PHASE3
Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Non-OpeRative MANagement of Rectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure
- Status
- COMPLETED
- Phase
- N/A
A Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106)
- Status
- TERMINATED
- Phase
- PHASE3
The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)
- Status
- COMPLETED
- Phase
- PHASE3